| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0054-0084-25 | 0054-0084 | HUMAN PRESCRIPTION DRUG | Zaleplon | Zaleplon | CAPSULE | ORAL | 20080606 | N/A | ANDA | ANDA077237 | Hikma Pharmaceuticals USA Inc. | ZALEPLON | 5 mg/1 | 100 CAPSULE in 1 BOTTLE (0054-0084-25) |
| 0054-0085-25 | 0054-0085 | HUMAN PRESCRIPTION DRUG | Zaleplon | Zaleplon | CAPSULE | ORAL | 20080606 | N/A | ANDA | ANDA077237 | Hikma Pharmaceuticals USA Inc. | ZALEPLON | 10 mg/1 | 100 CAPSULE in 1 BOTTLE (0054-0085-25) |
| 43063-912-10 | 43063-912 | HUMAN PRESCRIPTION DRUG | Zaleplon | Zaleplon | CAPSULE | ORAL | 20181205 | N/A | ANDA | ANDA077237 | PD-Rx Pharmaceuticals, Inc. | ZALEPLON | 10 mg/1 | 10 CAPSULE in 1 BOTTLE, PLASTIC (43063-912-10) |